EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Lauric acid with or without levodopa ameliorates Parkinsonism in genetically modified model of Drosophila melanogaster via the oxidative–inflammatory–apoptotic pathway

Olumayowa K Idowu iD, Olufunke O Dosumu, Ayodeji S Boboye, Ademola A Oremosu, Abdullahi A Mohammed iD

Brain and Behavior · 2024

DOI: 10.1002/brb3.70001 ↗

At a glance

Journal article in Brain and Behavior, 2024. Written by Olumayowa K Idowu and 4 co-authors. Institution: Department of Anatomy, College of Medicine, University of Lagos, Lagos, Nigeria. Major MEDLINE topics: Drosophila melanogaster, Lauric Acids, Parkinsonian Disorders, Levodopa. Cited 5 times so far (Crossref); 99 references. The full text is freely available (open access, CC BY 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Parkinson's disease (PD), the most prevalent type of Parkinsonism, is a progressive neurological condition characterized by a range of motor and non‐motor symptoms. The complicated etiology of PD is thought to involve a summation of aging, genetic predisposition, and environmental variables. However, the α‐synuclein protein plays a significant role in the disease's pathophysiology. Materials and methods The UAS‐α‐Syn and Ddc‐Gal4 strains were crossed to produce offspring referred to as PD flies. The entire population of flies was divided into five groups, each having about 100 flies and five replicates. The control group (w 1118 ) and the PD group not receiving treatment were exposed to lauric acid (LA)/levodopa (LD)‐free diet, while the PD groups that received treatments were fed with either a 250 mg/kg LA diet, a 250 mg/kg LD diet, or a combination of the two for 21 days. Longevity, geotaxis, and olfactory assays were performed in addition to other biochemical tests.

Results

As a result of the overexpression of α‐synuclein, the locomotive capacity, lifespan, and antioxidant status were all significantly ( p < .05) reduced, and the apoptotic and neuroinflammatory activities were increased. Nevertheless, the majority of the treated flies improved significantly ( p < .05).

Conclusion

LA, whether combined with LD or not, elicited a significant response in α‐synuclein/dopa decarboxylase genetically modified Drosophila melanogaster Parkinsonism models.

Subjects

MeSH terms (MEDLINE)

Drosophila melanogasterLauric AcidsParkinsonian DisordersLevodopaApoptosisDisease Models, AnimalAnimalsalpha-SynucleinAnimals, Genetically ModifiedOxidative StressLongevityMale

Author keywords

Drosophila melanogasterParkinson's diseaseapoptosisdopa decarboxylaselauric acidneuroinflammationα‐synuclein

Substances

Lauric Acidslauric acidLevodopaalpha-Synuclein

Authors and institutions

  • Department of Anatomy, College of Medicine, University of Lagos, Lagos, Nigeria.
  • Department of Anatomy, College of Health Sciences, Osun State University, Osogbo, Nigeria.
  • Department of Anatomy, College of Health Sciences, Federal University of Technology, Akure, Nigeria.
  • Department of Human Anatomy, School of Medicine and Pharmacy, College of Medicine and Health Sciences, University of Rwanda, Butare, Rwanda.

ORCID profiles: Olumayowa K Idowu, Abdullahi A Mohammed

Cite

APA

Idowu, O. K., Dosumu, O. O., Boboye, A. S., Oremosu, A. A., & Mohammed, A. A. (2024). Lauric acid with or without levodopa ameliorates Parkinsonism in genetically modified model of Drosophila melanogaster via the oxidative–inflammatory–apoptotic pathway. Brain and Behavior. https://doi.org/10.1002/brb3.70001

Vancouver

Idowu OK, Dosumu OO, Boboye AS, Oremosu AA, Mohammed AA. Lauric acid with or without levodopa ameliorates Parkinsonism in genetically modified model of Drosophila melanogaster via the oxidative–inflammatory–apoptotic pathway. Brain and Behavior. 2024. doi:10.1002/brb3.70001

BibTeX
@article{Idowu2024,
  author = {Idowu, Olumayowa K and Dosumu, Olufunke O and Boboye, Ayodeji S and Oremosu, Ademola A and Mohammed, Abdullahi A},
  title = {Lauric acid with or without levodopa ameliorates Parkinsonism in genetically modified model of Drosophila melanogaster via the oxidative–inflammatory–apoptotic pathway},
  journal = {Brain and Behavior},
  year = {2024},
  doi = {10.1002/brb3.70001}
}
Start for free →